PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 21, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	7	18	51	48	42	36
Market Cap Growth	-40.73%	-64.81%	5.50%	14.27%	16.41%	-21.44%
Enterprise Value	-10	-20	-22	-38	39	36
Last Close Price	1.04	2.12	2.92	2.33	26.57	36.75
PB Ratio	0.18	0.40	0.70	0.54	6.33	7.13
P/TBV Ratio	0.19	0.69	0.74	0.56	13.50	23.58
Debt / Equity Ratio	-	-	-	-	0.01	0.04
Quick Ratio	14.03	31.60	115.99	121.24	3.04	0.87
Current Ratio	14.20	31.76	116.18	121.38	3.14	1.01
Return on Equity (ROE)	42.89%	0.57%	-5.31%	-8.78%	-60.35%	-75.57%
Return on Assets (ROA)	-4.89%	-6.12%	-4.92%	-5.60%	-33.37%	-40.03%
Return on Capital (ROIC)	-5.96%	-6.90%	-4.96%	-5.68%	-37.71%	-46.36%
Earnings Yield	138.31%	1.86%	-8.47%	-8.78%	-8.40%	-10.54%
Buyback Yield / Dilution	35.50%	50.84%	-25.56%	-971.73%	-60.24%	-23.23%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q